These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 1756420

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Oral propafenone for rapid conversion of recent onset atrial fibrillation--a review.
    Hughes C, Sunderji R, Gin K.
    Can J Cardiol; 1997 Sep; 13(9):839-42. PubMed ID: 9343033
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Efficacy of cibenzoline in the termination and long-term prevention of paroxysmal atrial fibrillation: analysis based on the time of onset].
    Komatsu T, Nakamura S, Kimura M, Owada S, Saito E, Kobayashi T, Okumura K.
    J Cardiol; 2001 Feb; 37(2):75-82. PubMed ID: 11255698
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Long-term follow-up of right atrial multilinear high-frequency ablation in the treatment of recurrent paroxysmal atrial fibrillation].
    Dierkes S, Hennersdorf MG, Vester EG, Perings C.
    Dtsch Med Wochenschr; 2003 Jan 24; 128(4):130-4. PubMed ID: 12589581
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Incidence of atrial fibrillation post-cavotricuspid isthmus ablation in patients with typical atrial flutter: left-atrial size as an independent predictor of atrial fibrillation recurrence.
    Ellis K, Wazni O, Marrouche N, Martin D, Gillinov M, McCarthy P, Saad EB, Bhargava M, Schweikert R, Saliba W, Bash D, Rossillo A, Erciyes D, Tchou P, Natale A.
    J Cardiovasc Electrophysiol; 2007 Aug 24; 18(8):799-802. PubMed ID: 17593230
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Pharmacogenetic study of the response to flecainide and propafenone in patients with atrial fibrillation].
    Martínez-Sellés M, Castillo I, Montenegro P, Martín ML, Almendral J, Sanjurjo M.
    Rev Esp Cardiol; 2005 Jun 24; 58(6):745-8. PubMed ID: 15970126
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Benign symptomatic premature ventricular complexes: short- and long-term efficacy of antiarrhythmic drugs and radiofrequency ablation.
    Stec S, Sikorska A, Zaborska B, Kryński T, Szymot J, Kułakowski P.
    Kardiol Pol; 2012 Jun 24; 70(4):351-8. PubMed ID: 22528707
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Control of paroxysmal atrial fibrillation recurrence using combined administration of propafenone and quinidine.
    Lau CP, Chow MS, Tse HF, Tang MO, Fan C.
    Am J Cardiol; 2000 Dec 15; 86(12):1327-32. PubMed ID: 11113407
    [Abstract] [Full Text] [Related]

  • 40. Propafenone in the prevention of non-ventricular arrhythmias associated with the Wolff-Parkinson-White syndrome.
    Vassiliadis I, Papoutsakis P, Kallikazaros I, Stefanadis C.
    Int J Cardiol; 1990 Apr 15; 27(1):63-70. PubMed ID: 2335410
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.